Interleukin-6
9
0
0
8
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 9 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 8 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 8 completed trials
Clinical Trials (9)
The Predictive Role of Preoperative Pentraxin-3 (PTX3) in Metabolic and Inflammatory Outcomes After Roux-en-Y Gastric Bypass
Dynamics of microRNA Expression and Systemic Inflammatory Response in POCD After Cardiac Surgery
Interleukin-6 in Plaque Psoriasis and Its Possible Role in Disease Severity
Effect of Interleukin-6 Receptor Inhibition in Patients With Ischemic Stroke Undergoing Endovascular Treatment
Music Therapy on Neutrophyl Lymphocytes Ratio, Interleukin 6 and Interleukin 10 Levels of Burnout Syndrome
Characterization of Natural IL-6 Inhibition in Healthy Individuals
Effectivity of Bilateral Transversus Thoracis Muscle Plane Block After Open Heart Surgery
Effectiveness of the Cytokine Hemadsorption on Sepsis
Inflammatory Stress Response in Pediatric Inguinal Hernia Repair